Intron Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 12.80 Cr
as on 16-11-2024
- Paid Up Capital ₹ 10.32 Cr
as on 16-11-2024
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 23.80 Cr
as on 16-11-2024
- Satisfied Charges ₹ 22.00 Cr
as on 16-11-2024
- Revenue 25.00%
(FY 2023)
- Profit -10.99%
(FY 2023)
- Ebitda 35.85%
(FY 2023)
- Net Worth -16.34%
(FY 2023)
- Total Assets 8.46%
(FY 2023)
About Intron Life Sciences
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 12.80 Cr and a paid-up capital of Rs 10.32 Cr.
The company currently has active open charges totaling ₹23.80 Cr. The company has closed loans amounting to ₹22.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Intron Life Sciences Private Limited India is Ronak Modi as COMPANY SECRETARY. Sreemannarayana Pasumarthi, Pavan Velpuri, and Nithyagovind serve as directors at the Company.
- CIN/LLPIN
U24299AP2018PTC109365
- Company No.
109365
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Sep 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Prakasam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Intron Life Sciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreemannarayana Pasumarthi  | Managing Director | 28-Sep-2018 | Current |
| Ronak Modi | Company Secretary | 02-Nov-2022 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pavan Velpuri | Whole-Time Director | 28-Sep-2018 | Current |
| Nithyagovind | Director | 04-Dec-2018 | Current |
Financial Performance and Corporate Structure Insights of Intron Life Sciences.
Intron Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25% increase. The company also saw a substantial fall in profitability, with a 10.99% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Intron Life Sciences?
In 2023, Intron Life Sciences had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kph Infotech Private LimitedActive 4 years 2 monthsSreemannarayana Pasumarthi and Pavan Velpuri are mutual person
Exome Life Sciences Private LimitedActive 7 years 8 monthsSreemannarayana Pasumarthi and Pavan Velpuri are mutual person
Biome Biologicals Private LimitedActive 3 years 10 monthsSreemannarayana Pasumarthi, Pavan Velpuri and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 15 Nov 2023 | ₹2.09 M | Open |
Hdfc Bank Limited Creation Date: 09 Feb 2023 | ₹6.10 M | Open |
Axis Bank Limited Creation Date: 13 Jan 2023 | ₹22.30 Cr | Open |
How Many Employees Work at Intron Life Sciences?
Intron Life Sciences has a workforce of 160 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Intron Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intron Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
